Canada - Re-Export of Penicillins or Streptomycins in Dosage Forms

Since 2014, Canada Re-Export of Penicillins or Streptomycins in Dosage Forms was up 165.4% year on year. In 2019, the country was number 8 among other countries in Re-Export of Penicillins or Streptomycins in Dosage Forms with $454,407.09. Canada is overtaken by Kenya, which was number 7 at $610,638.88 and is followed by Cyprus with $401,376.21. Italy topped the ranking with $158,707,704.07 in 2019, -22% versus 2018. United States, United Arab Emirates and Saudi Arabia respectively ranked number 2, 3 and 4 in this ranking. Kenya witnessed the best average annual growth at +205.7% per year, while Trinidad and Tobago recorded the worst performance at -27.8% per year.

Loading...

Date US Dollars
2019 454,407.09
2018 155,031.08
2017 13,518.46
2016 109,766.91
2015 8,649.28
Download all data from 2000 to 2019

How does Canada rank in Re-Export of Penicillins or Streptomycins in Dosage Forms?

# 27 Countries US Dollars Last YoY 5‑years CAGR
1 #1
Italy
158,707,704.07 2019 -22.0 % +57.7 % View data
2 #2
United States
21,398,977.04 2019 +3.5 % +117.4 % View data
7 #7
Kenya
610,638.88 2018 +28.3 % +205.7 % View data
8 #8
Canada
454,407.09 2019 +193.1 % +165.4 % View data
9 #9
Cyprus
401,376.21 2019 +42.1 % +16.1 % View data
Compare all 27 countries

Go Top